Milrinone-Baxter Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Milrinone

Indications/Uses

Short-term IV treatment for acute decompensated heart failure.

Dosage/Direction for Use

IV Loading dose Administer 50 mcg/kg slowly over 10 min. Patient weighing 120 kg 6 mL, 110 kg 5.5 mL, 100 kg 5 mL, 90 kg 4.5 mL, 80 kg 4 mL, 70 kg 3.5 mL, 60 kg 3 mL, 50 kg 2.5 mL, 40 kg 2 mL, 30 kg 1.5 mL. Maintenance dose Administer as continuous infusion. Min: 0.375 mcg/kg/min; 0.59 mg/kg. Standard: 0.5 mcg/kg/min; 0.77 mg/kg. Max: 0.75 mcg/kg/min; 1.13 mg/kg. Renal impairment CrCl 50 mL/min/1.73 m² 0.43 mcg/kg/min, 40 mL/min/1.73 m² 0.38 mcg/kg/min, 30 mL/min/1.73 m² 0.33 mcg/kg/min, 20 mL/min/1.73 m² 0.28 mcg/kg/min, 10 mL/min/1.73 m² 0.23 mcg/kg/min, 5 mL/min/1.73 m² 0.2 mcg/kg/min.

Contraindications

Hypersensitivity.

MIMS Class

Cardiac Drugs

ATC Classification

C01CE02 - milrinone ; Belongs to the class of phosphodiesterase inhibitors. Used in the treatment of hypotension.

Regulatory Classification

POM

Presentation/Packing

Form

Milrinone-Baxter conc for soln for inj 10 mg/10 mL

Packing/Price

1's

Milrinone-Baxter

milrinone

Manufacturer:

Baxter Healthcare